Viewing Study NCT01671956

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:17 PM
Ignite Modification Date: 2026-02-22 @ 9:39 AM
Study NCT ID: NCT01671956
Status: TERMINATED
Last Update Posted: 2025-11-25
First Post: 2012-08-09
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Evaluation of Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of Bertilimumab in Patients With Active Moderate to Severe Ulcerative Colitis
Sponsor: Alexion Pharmaceuticals, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ulcerative Colitis, Active Moderate View
None Ulcerative Colitis, Active Severe View
Keywords:

Keywords

Keyword Brief Keyword Text View
None IBD View
None UC View
None Colitis View
None Ulcerative Colitis View